The biotech boom that began last year has triggered triple-digit gains in some of the market’s best penny stocks.
And some of our top penny stocks in biotech that we recommended last year gained as much as 440%, 231%, and 214%.
Better yet, the biotech sector is expected to keep surging — especially the sector’s best low-priced buys.
Keep in mind, investing in penny stocks isn’t for everyone, as they operate differently than the typical stock.
However, there are plenty of legitimate and lucrative penny stocks,
if you know how to invest. The key is finding the promising ones and
steering clear of the rest. (more)
Please share this article
Today KWN is pleased to share an important piece from 50-year veteran Art Cashin, who is Director of Floor Operations at UBS ($650 billion under management). Cashin discusses the Fed decision and why the markets may turn “hyper-volatile.” This is an extremely important piece that includes a fascinating guest commentary on the turmoil taking place overseas.
By Art Cashin Director of Floor Operations at UBS
January 29 (King World News) – “On this day (+1) in 1876, an already legendary medical professor at Edinburgh University began to address a new group of students. He began his lecture with his usual demand for observation. He pounded on his theme of the “vast importance of little distinctions” of the “endless significance of trifles.” “Yeah, yeah!” thought the students (or whatever the 1870′s equivalent of a cynical “yeah, yeah” was). Sure you’re a famous surgeon and professor but what will all this minutia get us.
He called for the first patient. Then, according to published reports, the following happened -
A man walked in and stood for a moment. The professor walked around him slowly, twice. Then the professor said something like – “Army…recently discharged….probably Scots Highland regiment. (“Aye! Sir!” came the reply). Next – you were likely a non-commissioned officer…likely in the West Indies - perhaps Barbados.”
READ MORE